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Choroid plexus tumours are rare epithelial brain tumours and limited information is available regarding their biology and the
best treatment. A meta-analysis was done to determine prognostic factors and the inﬂuence of various treatment modalities.
A thorough review of the medical literature (1966–1998) revealed 566 well-documented choroid plexus tumours. These
were entered into a database, which was analysed to determine prognostic factors and treatment modalities. Most patients
with a supratentorial tumour were children, while the most common sites in adults were the fourth ventricle and the
cerebellar pontine angle. Cerebellar pontine angle tumours were more frequently benign. Histology was the most important
prognostic factor, as one, ﬁve, and 10-year projected survival rates were 90, 81, and 77% in choroid plexus-papilloma (n=353)
compared to only 71, 41, and 35% in choroid plexus-carcinoma respectively (P50.0005). Surgery was prognostically relevant
for both choroid plexus-papilloma (P=0.0005) and choroid plexus-carcinoma (P=0.0001). Radiotherapy was associated with
signiﬁcantly better survival in choroid plexus-carcinomas. Eight of 22 documented choroid plexus-carcinomas responded to
chemotherapy. Relapse after primary treatment was a poor prognostic factor in choroid plexus-carcinoma patients but not in
choroid plexus-papilloma patients. Treatment of choroid plexus tumours should start with radical surgical resection. This
should be followed by adjuvant treatment in case of choroid plexus-carcinoma, and a ‘wait and see’ approach in choroid
plexus-papilloma.
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Choroid plexus tumours (CPTs) are relatively rare primary brain
tumours arising from epithelial differentiated tissue. With an
annual incidence of 0.3 cases per million (Janisch and Staneczek,
1988, 1989), these tumours account for only 0.4–0.8% of all brain
tumours (Zu ¨lch, 1957). The most commonly reported locations are
the ventricles. Nevertheless, extraventricular sites have been
described (Kimura et al, 1992; Steven et al, 1996; Mottl et al,
1997; Nakano et al, 1997), too. Tumours are classiﬁed as choroid
plexus-carcinoma (CPC, WHO grade III) (Kleihues and Canvanell,
2000), when they show nuclear pleomorphism, high nucleus to
cytoplasm ratios, blurring of the papillary pattern, and necrosis
(Paulus and Janisch, 1990). In addition, these tumours frequently
express carcinoembryonic antigen (CEA) (Paulus and Janisch,
1990), and CD44 (Varga et al, 1996) which can also be detected
as a marker in peripheral blood (Hashizume et al, 1995). Choroid
plexus-papilloma (CPP, WHO grade I), the more differentiated
tumours, expresses more frequently the markers pre-albumin
(Matsushima et al, 1988) and the S100 protein. The average label-
ling indices with MIB1, a proliferation marker, were 14% in CPC
and 3.7% in CPP (Vajtai et al, 1996). However, this histological
classiﬁcation is not clear cut. The possibility of a development from
papilloma to carcinoma has been documented (Diengdoh and
Shaw, 1993), and metastases occur not only in patients with
CPC (Bennedback and Therkildsen, 1990; Kang et al, 1997) but
also in patients with CPP (Leys et al, 1986; Domingues et al,
1991; Enomoto et al, 1991).
The current treatment of choroid plexus tumours is based on
little evidence. None of the national paediatric oncology groups
cover a population large enough to perform a randomised trial.
In general it is believed that surgical resection is an important
element of treatment. Postoperatively, infants with choroid plexus
carcinoma are frequently treated with adjuvant chemotherapy
and adult patients are treated with irradiation therapy. Patients
with choroid plexus papilloma are mostly treated similar to those
with low grade glioma. We performed a systematic literature
review to assess prognostic factors and treatment efﬁcacy in
choroid plexus tumours as a basis for stimulating an interna-
tional consensus to form the basis of an international trial
working group mainly within the International Society for
Paediatric Oncology (SIOP).
METHODS
The ﬁrst step for this analysis was a literature search in the Medline
database, including all publications up to January 1998. Search
words used were ‘Choroid plexus’ or ‘CPT’ or ‘CPP’ limited to
‘human’. This yielded 4120 titles of which 1520 appeared promis-
ing to contain the information listed below. Reading the abstracts
reduced this number to 551. However, reading those publications
increased the number again, because the referee list of some of
them contained publications, which had not been found in
Medline. Some of those were chapters in textbooks (Rubinstein
and Brucher, 1981; Kleihues et al, 1997). This yielded binally a total
of 572 publications.
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www.bjcancer.comThe second step was to create a patient database from cases
mentioned in the literature. Documented ﬁelds included ﬁrst
author, publication year, symptoms and signs, duration of symp-
toms until diagnosis, age at diagnosis, race, gender, histology,
size of tumour, location, presence of metastases, type of surgery,
type of radiotherapy, radiotherapy response, type of chemotherapy,
chemo-response, tumour recurrence, observation time, and
outcome. When tumours were diagnosed at autopsy or when
patients died during the ﬁrst surgery, they were encoded as obser-
vation time=0 and outcome=death. Patients published without any
observation time and without outcome description were encoded
as observation time=0, outcome=survival. Not all of these ﬁelds
collected sufﬁcient information for ﬁnal analysis. Publications were
excluded from the analysis when extractable information ﬁlled less
than two ﬁelds of the database. In case of replicated publications
from the same group, only the most recent publication was used
for data-entry.
The database was ﬁrst analysed using the technique of the stra-
tiﬁed subgroup analyses with ‘SPSS
1’ (SPSS Inc, San Francisco,
CA, USA). First the qualitative parameters such as tumour loca-
tion, histology, and gender were used to divide the database in
various groups. w
2 or Fishers exact tests and ANOVA were used
to assess the homogeneity for other parameters within these groups
and subgroups. Survival was analysed using Kaplan–Meier esti-
mates and compared with log rank tests. Cox regression analysis
was then used to repeat analyses for the same questions.
RESULTS
After applying the exclusion criteria, 217 publications were left
with sufﬁcient information. The number of patients reported with-
in each study was between one and 54 (Palazzi et al, 1989). This
resulted in a database of 566 patients.
Gender, age at diagnosis, location, histology and metastases
could be correlated to each other regardless if treatment or
observation time data were sufﬁcient. Surprisingly, none of these
parameters was distributed homogeneously among groups deﬁned
by the others. In the total group, the male:female ratio was
1.2:1. Relating gender to location showed relatively more female
patients with tumours located in the cerebellopontine angle
(CPA, 29 observed, 20 expected). Age at diagnosis covered a
large range from 0 years (foetus) to 72 years, but most of the
patients were children, resulting in a median age at diagnosis
of 3.5 years in the whole database. The most striking inhomo-
geneity was found when relating age to location (Figure 1).
The age distribution shifted from younger to older patients the
more caudal the tumour was located. This resulted in median
ages of 1.5 years, 1.5 years, 22.5 years, and 35.5 years in the
groups of tumours located in the lateral ventricle, third ventricle,
fourth ventricle and CPA, respectively (P50.005 ANOVA). In
the total group, the number of CPP was higher than CPC
(353 vs 207). When relating malignancy to location, the relative
frequency of CPC was higher in lateral ventricles and CPP was
more frequent in CPA-tumours (P50.005). Overall 12% of
patients presented with metastatic disease. This frequency was
higher for those with CPC histology (P50.0005) and with supra-
tentorial location (P=0.04). However, numbers were too small
for subgroup analyses of this variable. The metastases occurred
predominantly along the cerebrospinal ﬂuid pathways (Allen et
al, 1992), other sites included abdomen (Geerts et al, 1996),
bone (Valladares et al, 1980), and lung (Sheridan and Besser,
1994). Abdominal seeding has been described in patients with
a ventricular-peritoneal shunt (McCallum et al, 1988) and one
case of metastasis to the tibia has been published (Hayakawa
et al, 1979). The symptom duration of patients with tumours
located in the cerebellopontine angle was longer than in other
patients.
When survival was used as endpoint, patients with observation
time equaling 0 were excluded. This left 266 patients for analysis.
In these patients, the prognostic relevance of the available variables
were assessed. In an univariant analysis, histology was a signiﬁcant
prognostic factor (Figure 2). One, ﬁve, and 10 year projected survi-
val rates of plexus carcinoma patients were 71, 41, 35% in
comparison to CPP patients with 90, 81, 77%, respectively (Figure
2, P50.0005 log-rank test). Some tumours were primarily
described as ‘atypical choroid plexus papilloma’. In second
surgeries or autopsies of these patients, a repeat histology was
frequently reported as CPC. The survival curve of those ‘atypical
CPP’ was between the curves of CPP and CPC, but the number
of cases was too small for a meaningful analysis.
When analysing age at diagnosis, the poorest survival was noted
for those over 40 years of age, followed by those under 10 years of
age, with the best outcome for those aged 10–40 years (Figure 3).
The gender and location parameters did not have prognostic rele-
vance. In the total group of CPT, metastasis was a signiﬁcant factor
in survival time (P=0.02), however, metastases were more frequent
in CPC, and in subgroup analyses the numbers became too small
for meaningful analysis.
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Figure 1 Age distribution of choroid plexus tumours: Supratentorial tumours occur most frequently in infants (A) n=188, while the age distribution of
infratentorial tumours is spread over all ages (B), n=71; P50.005, Mann–Whitney U-test). This analysis included only patients with documented primary
intracerebral locations.
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radiotherapy, and chemotherapy. Of those, surgery showed the
most striking differences (Figure 4). CPP patients with complete
resection had a 10-year survival rate of 85% (+10% standard
deviation). This compared to 56% with less than gross total resec-
tion and to a one year survival rate of only 50% in patients after
biopsy (P=0.002). CPC patients had a 2-year survival rate of
72% (+10%) vs 34% (+10%) for those with a gross total resec-
tion or an incomplete resection, respectively. For the analysis of
irradiation, the variable ‘malignancy’ and ‘surgery’ were used to
create subgroups. For CPC patients, those that received irradiation
did better than those without irradiation in both subgroups, after
complete and incomplete resection (Figure 5). In the subgroup
of patients with CPC who had gross total resection, there were
25 patients who further received irradiation and 24 patients who
did not receive irradiation. The comparison of these two groups
showed a signiﬁcant beneﬁt for patients receiving irradiation
(Wolff et al, 1999). The data of patients with incomplete resection
are shown in Figure 5. The survival time of 19 patients receiving
irradiation was signiﬁcantly better (P=0.029) than that of nine
patients not given irradiation. Response to chemotherapy was well
documented in CPC (Table 1). The overall response rate was 8 of
22. With these limited data the impact of chemotherapy on survi-
val could not be sufﬁciently analysed.
Relapse after treatment was documented in 52 cases. It was not
surprising that CPC patients who relapsed after treatment did
poorly. The projected 2-year survival rate for these patients was
54%, as compared to 62% for CPC patients in which relapse
was not mentioned. By contrast, CPP patients with documented
relapse had the same survival as CPP patients without relapse.
A further interesting difference between CPP and CPC came up
when the year of publication was analysed with respect to prog-
nosis. Surprisingly, there was no improvement of the CPC-
prognosis over the years. By contrast the survival of CPP patients
published after 1970 was superior to earlier publications (5-year
survival rate: 83%, n=132 vs 35%, n=12, signiﬁcant P50.0005,
log-rank test).
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Figure 2 Survival of patients published as CPP with CPC patients. Only
patients with observation times 40 and clear histological allocation were
included. Symbols indicate end of observation times of surviving patient
(=censored data). Statistically signiﬁcant: P50,0005, log rank test.
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Figure 3 Young children and patients over 59 years of age have a worse
prognosis as compared to the age classes in between (P50.0005 log rank
test). This included patients, in whom the observation time was 40, and in
whom age at diagnosis was documented. Survival rates were calculated as
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Figure 4 In both, CPC, (A) and CPP (B), the type of surgery was a statistically signiﬁcant prognostic factor (P=0.0001, and P50.00005, respectively, log
rank tests).
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This systematic literature review was initiated to determine risk
factors and the best management for choroid plexus tumours
(CPT). However, a literature review cannot produce the level of
evidence that one might wish for since there is no certain way to
control publication bias. Whenever possible, clinical treatment
decisions should be based on prospective randomised trials, but
in the absence of those, a systematic literature review might
provide the best possible evidence.
The etiology of some choroid plexus tumours has been linked
to SV40 infections (Tabuchi et al, 1978a,b; Bergsagel et al, 1992;
Lednicky et al, 1995; Martini et al, 1996), but it might also be
inﬂuenced by other factors such as X-chromosome linked
syndromes (Steichen-Gersdorf et al, 1993; Sybert et al, 1994;
Kleihues, 1997). We found signiﬁcant differences when relating
gender to age at diagnosis, tumour location or pathology. Cere-
bello-pontine angle tumours were associated with older age,
benign histology, and female gender. This could suggest a
tumour entity linked to a tumour-suppressor gene located on
the X-chromosome. Interestingly, the syndromes with defects
on the X-chromosome were reported with choroid plexus papil-
loma (Hamano et al, 1991; Steichen-Gersdorf et al, 1993; Sybert
et al, 1994; Triﬁletti et al, 1995; Zajac et al, 1997). By contrast,
the infant type of choroid plexus tumours was most frequently
located in the lateral ventricles and had a male predominance.
Interestingly, the report about SV40 in choroid plexus tumours
described children only (Bergsagel et al, 1992). Based on this
analysis we hypothesised that SV40 is more frequently found
in infant tumours and that there is a distinctly different aetiol-
ogy in adult choroid plexus tumours.
The deﬁnitive diagnosis of a choroid plexus-tumour can only be
made histologically. The allocation to either CPP or CPC might be
debatable in individual cases. In fact, others have found a signiﬁ-
cant number of tumours changing the allocated diagnosis, when
reviewed in a reference centre (Berger et al, 1998). Despite this,
our data show that the published histological diagnosis is a signiﬁ-
cant risk factor, even when reference pathology is missing in most
cases. Surgery is therefore required for the diagnosis. Tumour
resection is also a powerful therapeutical step. In both diagnoses,
CPC and CPP, the prognosis was better in completely resected
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Table 1 Response to multiagent chemotherapy in choroid plexus carcinoma
Author Pub. year Age/years Locaton Chemotherapy Response
Arico 1994 0.25 Lat.Vent VCR-CCNU-PRC-MTX SD
Allen 1992 1.5 Lat.Vent POG-BLEO VBL CR
Allen 1992 2.25 Lat.Vent POG CR
Allen 1992 0.75 Lat.Vent (VP-CDDP)(5FU-LEUCOV) SD
Geerts 1996 2.5 Lat.Vent VCR-VP16-CARB-CYC CR
Duffner 1995 1 Lat.Vent. VCR-CYC-VP16-CDDP SD
Duffner 1995 0.66 Lat.Vent VCR-CYC-VP16-CDDP SD
Duffner 1995 1.83 Lat.Vent VCR-CYC-VP16-CDDP PR
Duffner 1995 1.75 Lat.Vent VCR-CYC-VP16-CDDP PR
Packer 1992 2.75 Paranchy CDDP-VP16–5FU NR
Packer 1992 2.16 Paranchy CDDP-VP16-THIOTEPA NR
Packer 1992 2.58 Lat.Vent CYC-VCR-CDDP PD
Berger 1998 1.5 Infr.Tent. BB SFOP PD
Berger 1998 3.58 Supr.Tent VP16-CARB PD
Berger 1998 1.5 Supr.Tent BB SFOP PD
Berger 1998 2 Supr.Tent VP16, IFO, CARB CR
Berger 1998 1.91 Supr.Tent BB SFOP CR
Berger 1998 0.75 Infr.Tent. BB SFOP CR
Berger 1998 1.08 Supr.Tent CARB IFO SD
Berger 1998 2.75 Supr.Tent BB SFOP SD
Berger 1998 4 Supr.Tent BB SFOP SD
Berger 1998 3 Supr.Tent. VP16-CARB SD
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Figure 5 Inﬂuence of irradiation on survival with incompletely resected
CPC. Inclusion factors for this analysis were: Observation time 40, histol-
ogy CPC, surgery well documented, less than gross total resection. The dif-
ference in favour of irradiation is marginally statistically signiﬁcant (P=0.029,
log rank test).
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1992), the positive relevance of surgery appears to be greater than
in most other brain tumours. This supports a second surgery when
the post surgical radioimaging shows residual tumour.
In CPC patients adjuvant treatment should follow surgery.
Response to irradiation has been demonstrated in at least ﬁve
patients with residual tumour after surgery (Carrea and Polak,
1977; Naguib et al, 1981; Grifﬁn et al, 1988; Hashizume et al,
1995; Wolff et al, 2001). Based on our analysis, patients with
gross total resection should indeed receive irradiation. We
conﬁrmed signiﬁcant improved survival for patients with CPC
who received irradiation in both subgroups (a) with residual
tumour (Figure 5) and (b) after gross total resection (Wolff et
al, 1999). However, radiation is to be avoided in young children,
in whom long term sequelae are severe. This leaves chemother-
apy as adjuvant modality for the majority of patients.
Chemotherapy can result in shrinkage of CPC tissue (Table 1),
and chemotherapy has been recommended by some authors
(Duffner et al, 1995; Geerts et al, 1996), but the experience with
this modality has been limited, and evidence for an impact on
the number of long term surviving patients is still missing.
The numbers are simply too small to provide such evidence.
Similarly, the relative contribution of the various single agents
to response cannot be evaluated. A clinical study addressing that
question will need a patient population larger than any of the
current national paediatric oncology groups. This should there-
fore be done in an intercontinental setting. The fact that
prognosis of patients published prior to 1970 is unchanged to
the prognosis in the most recent publications warrants the start
of such an effort. Recurrence of CPC has to be judged incurable
with conventional treatment, and is therefore an indication for
experimental treatment.
CPP treatment should be different. Surgery appears to be the
most important modality in plexus papilloma (Raimondi and
Gutierrez, 1975; Schijman et al, 1990; Sharma et al, 1994; Tacconi
et al, 1996; Costa et al, 1997). Guidetti and Spallone (1981)
reported 50% survivors after surgery only already in 1981. In
infants, plexus papillomas are the brain tumours with the best
prognosis (McGirr et al, 1988; Tomita et al, 1988; Buetow et al,
1990). In contrast to CPC, there is no published evidence yet that
adjuvant treatment has any impact on survival of CPP patients.
Recurrences may occur as late as 11 years after diagnosis (Buetow
et al, 1990), which is much later than predicted by the Collins rule
(Valladares et al, 1980). However, in our analysis, the prognosis of
patients with CPP is still good when these patients relapse. The
better prognosis documented in publications after 1970 is most
likely caused by improvement of surgical and intensive care techni-
ques. Therefore, the data collected in this review further support a
‘wait and see’ policy after ﬁrst tumour resection.
In conclusion, the data generated in this meta-analysis supports
the hypothesis of distinct choroid plexus tumour subtypes which
differ in variables such as gender, age at diagnosis, prognosis, loca-
tion and malignancy. The previously known importance of gross
total resection was conﬁrmed by this analysis. In addition, evidence
was provided that adjuvant therapy increases survival in CPC
patients. This work was initiated by an international consensing
discussion, which has resulted in an international study to standar-
dise and optimise the therapy.
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